Abstract
Curcumin is a bioactive component with anticancer characteristics; nevertheless, it has poor solubility and fast metabolism, resulting in low bioavailability and so restricting its application. Curcumin loaded in nano emulsions (Cur-NE) was developed to improve water solubility and eliminate all the limitations of curcumin. Size distribution, zeta potential, transmission electron microscopy (TEM) measurements, UV–Visible spectra, IR spectra and thermogravimetric analysis (TGA), were used to characterize the prepared Cur-NE. Cancer therapeutic efficacy was assessed by oxidative stress (superoxide dismutase (SOD), Glutathione–S–Transferase (GST), malondialdehyde (MDA) and nitric oxide (NO), DNA damage, apoptotic proteins (caspase-3 and 9), besides investigating tumor histology and monitoring tumor growth. Additionally, the cytotoxicity and genotoxicity of the liver, kidney, heart, and spleen tissues were examined to gauge the adverse effects of the treatment method’s toxicity. The results showed that Cur-NE is more effective than free curcumin at slowing the growth of Ehrlich tumors while significantly increasing the levels of apoptotic proteins. On the other hand, Cur-NE-treated mice showed some damage in other organs when compared to mice treated with free curcumin. Cur-NE has a higher efficacy in treating Ehrlich tumor.
Similar content being viewed by others
Introduction
Cancer has become one of the most serious health issues in our decade, according to the American Cancer Society. Cancer is a term used to describe a group of cells that have oddly spread, invasion and metastasis1,2, and the most common reason for mortality is cancer in humans after cardiovascular disorders. Although great efforts have been made in developing treatment regimens such as chemotherapy, surgery, and radiotherapy, they have a significant negative impact on health. Therefore, several studies have been devoted to researching new methods aimed at finding treatments that have anti-proliferative effects on cancer cells while having less immune system side effects. As a result, researchers are investigating the combination between nanoscale particles and natural components (plants, animals, and microorganisms), which are considered novel strategies for cancer treatment3,4,5,6.
Natural phytochemicals have received several interests as anticancer and ant-inflammation medicines since they are less toxic to normal cells and have less side effects when compared to chemical medications7. The metabolites of phytochemicals, which also include alkaloids, flavonoids, phenolics, tannins, glycosides, gums, resins, and oils, have high anticancer potential and serve a variety of therapeutic purposes in human systems. There are various methods by which phytochemicals have anticancer effects. They selectively kill rapidly dividing cells, target incorrectly expressed molecular factors, eliminate oxidative stress, alter cell growth factors, block angiogenesis of malignant tissue and cause apoptosis8,9.
Curcumin is a natural hydrophobic polyphenol derived from the Curcuma longa plant that is suspected to have anticancer, chemo preventive, anti-inflammatory10,11, antibacterial, and antioxidant effects. Because of its several methods of action, it has a wide spectrum of qualities12,13,14. Curcumin’s anticancer properties are mediated through several methods. Curcumin triggers oxidative reactions and mitochondrial membrane breakdown by increasing ROS generation. As a result, the cell cycle is disrupted, and apoptosis is triggered. Curcumin interacts with enzymes, transcription factors, members of the Bcl-2 family, death receptors, and apoptotic proteins. As a result, cell proliferation is slowed15,16,17.
Unfortunately, all of curcumin’s beneficial chemoprotective effects are limited due to several major issues, including poor bioavailability, low solubility in water, rapid excretion, and higher rate of metabolic activity18. As a result, numerous technological methods for overcoming these issues and improving their qualities have been investigated. Wang et al.19 used full encapsulation of curcumin in sodium alginate/ZnO hydrogel beads to modulate curcumin delivery. Suryani et al.20 used low viscosity chitosan and tripolyphosphate at various concentrations to make curcumin nanoparticles, which they recommended as a promising anticancer treatment. Elbialy et al.21 produced iron oxide nanoparticles coated with curcumin to improve curcumin circulation and biodistribution. Also, Elbialy et al.22 encapsulated curcumin in mesoporous silica nanoparticles and reported that the formulation was useful for cancer therapy. Ben et al.23 employed a microemulsion to encapsulate the curcumin and used it as radioprotective.
In the current study, it is critical to investigate the synthesis and characterization of curcumin encapsulated in nano-emulsions, as well as its release. Secondly, the antitumor protentional of curcumin nano-emulsions compared with native curcumin in the in vivo system using Ehrlich tumor bearing mice as a model. Thirdly, the side effects on the vital organs (kidney, heart, spleen, and liver) were evaluated for all the treated mice groups and compared with untreated mice.
Materials and methods
Materials
Curcumin, lauric acid, Span® 20 (sorbitan laurate), Tween® 80 (polysorbate 80) and isopropyl myristate were acquired from Sigma-Aldrich and utilized without extra refining. Phosphate buffer (PBS) was obtained from MP Biomedical, LLC (USA), and nitric oxide assay (NO), Glutathione–S–transferase assay, lipid peroxidation (MDA) and superoxide dismutase (SOD) kits were obtained from bio diagnostic Co., Giza, Egypt.
Preparation of curcumin loaded in nano emulsions (Cur-NE)
Curcumin loaded in nano emulsion (Cur-NE) was created using the techniques described in Ben et al. and Kesisoglou and Panmai23,24,25. In a nutshell, Span® 20 (0.16 mL), Tween® 80 (3 mL), isopropyl myristate (0.6 mL), and lauric acid (100 mg) were mixed until a clear liquid was formed. Curcumin (125 mg) was added to the solution and stirred with a magnetic stirrer (MS-300HS, Misung Scientific, Gyeonggi-do, Korea) until the components were completely combined before adding 8 mL of distilled water drop by drop. It may take up to 24 h for curcumin nanoparticles to equilibrate. At room temperature, all processes were accomplished.
Characterization of curcumin free (CR) and curcumin nano emulsions (Cur-NE)
The size and shape of Cur-NE were observed by Transmission Electron Microscope (TEM, FEI Tecnai G20, Super twin, Double tilt, LaB6 Gun). The mean particle size, size distribution, and zeta potential for Cur-NE were examined by the dynamic light scattering device (Malvern Zetasizer Nano ZS Instruments Ltd, UK). Additionally, the structural characteristics of CR and Cur-NE were determined by the absorption spectra (JENWAY, 6405 UV/VIS. Spectrophotometer, Barloworld scientific, Essex, UK, λ = 250–600 nm), Fourier-Transform Infrared Spectroscopy (Basic Vector, 22FT-IR, Germany, λ−1 = 4000 and 400 cm−1 with 4 cm−1 resolve) and thermogravimetric analyzer (TGA) (DTG-60H, SHIMADZU, Japan, temperature range room temperature up to 400 °C at a rate of 10 °C/min). Furthermore, the encapsulation efficiency of curcumin in a nano emulsion and its release was performed accordingly to Avgoustakis et al.26, briefly, first, the encapsulation efficiency of Cur-NE was performed by measuring the absorbance of curcumin at different concentrations using a UV–Visible spectrophotometer at 435 nm. The standard curve of curcumin was prepared by plotting optical density against the concentrations and same was used for determining the concentration of curcumin in the supernatant. Second, the release of curcumin from Cur-NE was performed as followed, two suspensions of Cur-NE and CR were in two cellulose acetate dialysis chambers (Spectra/P or. MW cut-off 12,000, Spectrum, Canada), dipped in buffer (phosphate solution: Tween 8:2) and stirred at 50 rpm. At the waiting times, 2 mL of release buffer was withdrawn and immediately an extra 2 mL of new buffer was added and kept for up to 12 h. Curcumin concentrations in the release buffer were measured by spectrophotometry at 430 nm.
Animals and experimental design
Based on a review of approval number CU/I/F/1/21, the Cairo University Research Ethics Committee granted approval for a total of 20 albino mouse procedures and experimental protocols that were carried out in accordance with the Guide for the Care and Use of Laboratory Animals and Use Committee (CU-IACUC), which provide the policies, procedures, standards, organizational structure, staffing, facilities, and practices to achieve the humane care and use of animals in the laboratory. The National Cancer Institute (“NCI”), Cairo University, Giza, Egypt, provided male albino mice (average weight 25 g, 8–10 weeks old). The mice were housed in the lab for a week before the test as acclimatization under standard laboratory conditions. Separate cages were used to house the mice, and they had unrestricted access to clean, fresh water. Ehrlich ascites carcinoma (EAC) (Ehrlich ascites mammary carcinoma is a spontaneous murine mammary adenocarcinoma and it is one of the well-established models in cancer biology27 was bought from Cairo University’s Tumor Biology Department of the National Cancer Institute (“NCI”). The experimental production of solid tumor in male mice was carried out by subcutaneous injection of 0.1 mL of Ehrlich’s ascites carcinoma (2.5 × 106 cells/mL) to the right hind limb of each mouse under sterile conditions. 10–13 days after tumor injection, the tumor manifested and became palpable in the injected animals as shown in Fig. 1 and described by Abdelrahman et al.28.
Mice were separated into four groups (n = 5) at random: control, tumor, CR and Cur-NE group. Control and tumor groups were received orally PBS, CR and Cur-NE groups were received orally 20 mg/kg curcumin extract and 20 mg/kg curcumin loaded in nano emulsions respectively, every day for 2 weeks. Through the treatment procedure, the tumor size was examined every 3 days across a period of 12 days for all the experimental groups and estimated based on Ghous et al.29. At the end of the treatment protocol, all mice were sacrificed by sudden decapitation; tumor tissues, kidney, heart, spleen, and liver were instantly removed from each, cleaned with isotonic saline, split, and used for assessment (Fig. 2).
Oxidative stress analysis
The tumor, kidney, heart, spleen, and liver tissues of all mice groups were homogenized in cold phosphate-buffer, centrifuged at 4000 rpm (VS18000 M; Vision scientific, Korea) for 10 min and the supernatants were used for measuring the oxidative stress. The activity of superoxide dismutase (SOD) and Glutathione–S–Transferase (GST) and the level of malondialdehyde (MDA) and nitric oxide (NO) were determined using superoxide dismutase assay kit (SOD 2521), the Glutathione–S–Transferase assay kit (GST 2519), lipid peroxidation assay kit (MDA 2529), and nitric oxide assay kit (NO 2533) respectively, according to the manufacturer’s instructions.
Comet assay
Comet assay is a quick, easy, visible, and exact way to assess DNA destruction and the early stages of apoptosis30. DNA damage induced in tumor, kidney, heart, spleen, and liver tissues for all experimental groups was estimated by the Comet assay described by Rageh and El-Gebaly31. Briefly, comet assay was done under alkaline conditions (pH > 13), a sample (5 μL) of cell suspension was mixed with70 μL of 0.7% low-melting-point (LMP) agarose. Agarose was put on a microscope slide, which was previously covered with a thin layer of 0.5% normal melting point (NMP) agarose. After cooling at 4 °C for 5 min, slides were wrapped with a third layer of LMP agarose. After solidification at 4 °C for 5 min, slides were immersed in recently prepared cold lysis solution at 4 °C for at least 1 h. Subsequent lysis, slides were put in a horizontal gel electrophoresis unit and sit on in fresh alkaline electrophoresis buffer. Electrophoresis was done for 30 min at 24 V (∼ 0.74 V/cm) and 300 mA at 4 °C. Therefore, the slides were dipped in neutralizing buffer and lightly washed times for 5 min at 4 °C. All the procedures were completed under lowered light. Comets were visualized by ethidium bromide staining solution and examined at × 400 magnification using a fluorescence microscope. Comet 5 image analysis software exploited by Kinetic Imaging, Ltd. (Liverpool, UK) linked to a CCD camera was used to assess DNA damage in the cells by measuring the length of DNA migration and the percentage of migrated DNA. Tail moment and Olive moment were computed32.
Western blots
Western blotting analysis of caspase-3 and caspase-9 was completed using the procedure outlined in Lihua et al.33. All mice groups’ tumor tissues were homogenized, centrifuged and lysed in the radio-immunoprecipitation assay (RIPA) lysis buffer including a protease/phosphatase inhibitor cocktail and placing them on ice for 30 min until complete lysis was achieved. The lysate was transferred to an Eppendorf tube and centrifuged at 4 °C for 15 min at 13,000 rpm (VS18000 M; Vision scientific, Korea). SDS-PAGE (12% acrylamide) was used to separate the extracted proteins, which were then stained onto PVDF membranes. For normalization, antibodies against-actin were used to probe the membranes. The target proteins’ band intensities were compared to the control sample-actin (housekeeping protein) using protein normalization on the ChemiDoc MP imager using image analysis software.
Histological examination
All groups’ tumor samples were embedded in paraffin bars, fixed in 10% neutral buffered formalin solution, sectioned into 5 µm thick sections, and stained with hematoxylin and eosin (H&E) as pathologists and researchers usually utilize this stain as an initial evaluation since it gives a thorough picture of the microanatomy of a tissue34. For the inspection of tissue slices, an optical microscope (CX31 Olympus microscope, Tokyo, Japan) connected to a digital camera (Canon) was employed.
Statistical analysis
The data was examined using SPSS 19.0 for Windows, and the mean and standard deviation (SD) were displayed. One-way analysis of variance (one-way ANOVA) was used to calculate significant differences between groups; significant difference (LSD) was applied to multi-group evaluations. It was deemed significant at P ≤ 0.05.
Results and discussion
Curcumin is a polyphenol chemical found in nature. It’s regarded as a powerful anti-inflammatory and antioxidant. Because of these characteristics, it can be used to treat a wide range of cancers. Curcumin’s clinical use has been limited due to its lack of solubility, stability, bioavailability, and selectivity. As a result, several initiatives have been made in recent years to eliminate these problems and improve clinical applications, such as nano carriers, nanoparticles, micelles, solid dispersions and liposomes. The present study highlights the use of curcumin loaded in nano emulsions (Cur-NE) which has shown several major advantages, including higher physical stability and drug loading ability, low toxicity, and controlled drug release, and targeting18,35,36,37,38,39.
Cur-NE characterization
In the present study, Cur-NE was set according to the method of Ben et al. and Kesisoglou and Panmai23,24,25 and characterized using several techniques. The shape and size of Cur-NE were observed by TEM (Fig. 3). The round nanoparticles in the TEM image are evenly distributed, not aggregated, and range in diameter from 45 to 60 nm. The dynamic light scattering (DLS) measurement shown in Fig. 4a supports this finding. The size of Cur-NE is centered at 459 nm, (PDI = 0.604) with a reasonably narrow distribution but appears to be higher compared to TEM due to the interference of the dispersant to the hydrodynamic diameter. The potential analyzer was used to determine the electro-kinetic surface potential for Cur-NE (Fig. 4b). The value of zeta potential for Cur-NE is (− 16 mV ± 1.2). This result revealed that the particles were stable and evenly spread. These results matched those of Paolino et al.40, who stated that particles with a high negative or positive zeta potential are suspended. Because the particles are opposing each other, there will be no desire for them to stick together.
UV–Vis and FT-IR spectra were employed to support curcumin free (CR) and Cur-NE structure. Figure 5 shows the absorption spectra of CR and Cur-NE in the wavelength range 250–600 nm, where the absorption peaks centered at 510 nm and 420 nm for CR and Cur-NE respectively. The shift between the CR and Cur-NE absorption bands might be attributed to Cur-NE production and the alterations in the structure or chemical environment of the Cur-NE this result is consistent with Pandit et al. and Kumar et al.41,42.
The FT-IR spectra of CR and Cur-NE are presented in Fig. 6. Both samples exhibited characteristic peaks around 3532 cm−1 (O–H), 1500 cm−1 (–C=O), 1424 cm−1 (C–H), 1025 cm−1 (C–N) to 3450 cm−1 (O–H), 1465 cm−1 (–C=O), 1100 cm−1 (C–H), 960 cm−1 (C–N), 1624 cm−1 (C=C), 1591 cm−1 (benzene ring stretching vibrations), 1272 cm−1 (C–O), 1024 cm−1 (C–O–C)43,44. The spectra of CR and Cur-NE indicates a few changes in the structure which happened at the molecular level during the preparation of the nanocurcumin45.
Thermal analyses are necessary to determine the thermal variations in compounds and the maximum temperature to which they can be exposed without losing their properties. Thus, thermogravimetric analysis (TGA), which tracks mass variations, was used to assess CR and Cur-NE thermal stability (Fig. 7). The TGA curves of CR and Cur-NE indicated to a weight loss 2% and 18% in temperature ranges 25–75 °C and 25–150 °C respectively, the increase in weight loss in Cur-NE might be attributed to the present of water and organic solvents in the formulation. Moreover, higher decomposition temperature suggests that increased thermal stability and heat tolerance for Cur-NE46,47. Furthermore, encapsulation efficiency of loaded curcumin in nano emulsions (NE) is an important characteristic, hence, at the current study, the encapsulation efficiency of curcumin in Cur-NE was 85%. This finding suggests that the NE may keep a high quantity of curcumin48 due to stronger non-covalent interactions between the curcumin and the compounds of the formulation and/or due to the bigger volume available to incorporate the curcumin.
Figure 8 reveals the performance of in vitro release of free curcumin and Cur-NE. As shown in the figure, more than 60% of the free curcumin is released within 6 h, while Cur-NE displays gradual release around a long period of time with just 20% curcumin released within 6 h. The in vitro release study of curcumin displayed no outbreak result so that the drug passage out of the nanoparticles was regulated mainly by a diffusion-controlled mechanism. Mohamad et al.49 reported that slow release due to intermolecular interaction with the near environment. Furthermore, the NE is suitable for drug carriers due to high encapsulation efficiency and control the release. Hossann et al.50 confirmed this finding, reporting that the shielding effect of the lipid bilayer in liposomes mediated drug delivery was observed to be sustained and prolonged drug release pattern to the targeted areas.
Cur-NE therapeutic efficacy in solid Ehrlich carcinoma-bearing mice
Tumor size, oxidative stress, histology, DNA damage and apoptotic proteins were used to assess Cur-NE therapeutic efficacy in solid Ehrlich carcinoma-bearing mice. Oxidative stress and DNA damage were also considered in the liver, kidney, heart, and spleen to recommend the suggested treatment mode, where these organs are the initial sites for the accumulation of foreign substances associated with the pathogenesis of systemic diseases51.
Oxidative stress
When compared to normal cells, cancer cells produce reactive oxygen species (ROS) at a higher rate, altering the redox environment. MDA is a biomarker of oxidative stress since it is the byproduct of lipid peroxidation, and its level is associated with tumor progression. Simultaneously, SOD activity is lowered to protect the animals from ROS52,53,54. Moreover, most chemotherapeutics mediators raise intracellular levels of ROS, and can alter redox homeostasis of cells55. Consequently, treatment with curcumin free and Cur-NE were evaluated by the activity of SOD, GST and the level of MDA and NO in kidney, liver, heart, spleen, and tumor tissues (Fig. 9a–d). Figure 9a demonstrates a significant decrease in NO levels in the range (20–50%), in the mice group treated by Cur-NE compared to control group. Figure 9b,c, show a significant decrease in the activity of GST and SOD in the range (35–80%) and (2–35%) respectively in the mice group treated by Cur-NE compared to the control one. Also, Fig. 9d shows a significant increase in the level of MDA in the range (40–85%) in the mice group treated by Cur-NE compared to the control one. These results are coherent with several studies that documented curcumin treatment combined with increased ROS production and disruption of the antioxidant system56,57,58,59.
Comet assay
Modulation of oxidative stress by curcumin and Cur-NE is reflected in DNA damage. Comet assay from kidney, liver, heart, spleen, and tumor tissues showed comet growth in the treatment groups. Thus, DNA damage was measured as %DNA in tail, olive tail moment, tail length and tail moment (Fig. 10a–e)60,61. Mice groups treated with Cur-NE revealed a significant increase in the percentage of DNA (%DNA) in tail, olive tail moment, tail length and tail moment in the kidney, liver, heart, and spleen tissues in the range (2.6–57%) compared to the control group (Fig. 10a–d). On the other hand, tumor tissues showed a nonsignificant result compared to the control group. This data were proven by the comet images in Fig. 10e. These results may be due to the small size of Cur-NE which permits it to enter mitochondria and nuclear pores and the ability of curcumin to regulate cellular redox stability by distracting mitochondrial homeostasis and improving cellular oxidative stress. Furthermore, curcumin causes ROS creation and decreases mitochondrial transmembrane potential thereby activating DNA damage/repair pathway and mitochondrial apoptosis62. Additionally, a nonsignificant result in tumor tissues might be due to lack of genotoxicity of the Cur dose.
Histopathological examination
Curcumin triggers mitochondrial permeability which lead to mitochondrial swelling, loss of mitochondrial membrane potential, embarrassment of mitochondrial function, hence, initiation of cellular apoptosis in cancer cells63. These results are displayed in the histopathological variation in striated skeletal muscles (Fig. 11a–d). Figure 11a shows a normal striated skeletal muscle for the normal mice compared to marked pleomorphism, hyperchromatism and mitotic activity for tumor cells in the skeletal muscles in Ehrlich carcinoma-bearing mice (Fig. 11b). On the other hand, mice group treated with CR shows masses of pleomorphic and anisokaryotic tumor cells penetrating striated muscles (Fig. 11c). While the group treated with Cur-NE shows the inhibition of tumor cells embedded in the muscles, as in Fig. 11d.
Western blot
Figure 12a–c illustrates the expression of apoptotic proteins in Ehrlich ascites carcinoma treated with curcumin and Cur-NE. In association to the control group, the level of caspases 3 and 9 significantly increased by around 1- and 3.5-fold, respectively. These results are consistent with the findings of other research64,65 that suggest curcumin can cause oxidative stress, resulting in mitochondrial malfunction and an imbalance in antioxidant defiance. Hence, apoptotic proteins are activated, resulting in cell death (Supplementary Information).
Tumor growth
Curcumin and Cur-NE cause oxidative stress, DNA damage, apoptotic proteins, and histological alterations, which result in tumor shrinking and a delay in tumor growth (Fig. 13). Figure 12 shows that tumor volumes clearly rise over time in the control group. It also be noted that mice groups treated with curcumin and Cur-NE showed obstacles in tumor growth rate compared with the control one. Based on previous studies these results may be due to the ability of curcumin to generate free radical-driven apoptosis and/or necrosis of tumor cells66.
Conclusion
The current Cur-NE was created and characterized using several tools. The formulation demonstrated great encapsulation efficiency and improved regulated curcumin release. Cur-NE and free curcumin were used to cure solid Ehrlich tumor implanted in Balb/c mice. According to the combined findings, Cur-NE was a successful treatment when compared to free curcumin, with little cytotoxicity for the essential organs.
Guideline
The study is reported in accordance with Guide for the Care and Use of Laboratory Animals and Use Committee (CU-IACUC) number CU/I/F/1/21.
The current study was carried out in compliance with the ARRIVE guidelines when relevant methods were applied.
Data availability
The datasets generated during and/or analyzed during the current study are available from the corresponding author on reasonable request.
References
Bergfeld, S. A., Blavier, L. & De Clerck, Y. A. Bone marrow-derived mesenchymal stromal cells promote survival and drug resistance in tumor cells. Mol. Cancer Ther. 13(4), 962–975. https://doi.org/10.1158/15357163.MCT-13-0400 (2014).
Siegel, R. L., Miller, K. D. & Jemal, A. Cancer statistics. CA Cancer J. Clin. 66(1), 7–30. https://doi.org/10.3322/caac.21332 (2016).
Cragg, G. M. & Newman, D. J. Plants as a source of anti-cancer agents. J. Ethnopharmacol. 100, 72–79. https://doi.org/10.1016/j.jep.2005.05.011 (2005).
Rageh, M. M., El-Gebaly, R. H. & Affi, M. M. Antitumor activity of silver nanoparticles in Ehrlich carcinoma-bearing mice. NaunynSchmiedeberg’s Arch. Pharmacol. 391(12), 1421–1430 (2018).
Rageh, M. M. & El-Gebaly, R. H. Antioxidant activities of α-lipoic acid free and nano-capsule inhibit the growth of Ehrlich carcinoma. Mol. Biol. Rep. 46(3), 3141–3316 (2019).
Affi, M. M., El-Gebaly, R. H. & Abdelrahman, I. Y. Efficacy of iron–silver bimetallic nanoparticles to enhance radiotherapy. Naunyn-Schmiedeberg’s Arch. Pharmacol. https://doi.org/10.1007/s00210-023-02556-9 (2023).
Mohamad, E. A., Mohamed, Z. N., Hussein, M. A. & Elneklawi, M. S. GANE can improve lung fibrosis by reducing inflammation via promoting p38MAPK/TGF-β1/NF-κB singling pathway down-regulation. ACS Omega 7(3), 3109–3312 (2022).
Singh, S., Jarial, R. & Kanwar, S. S. Therapeutic effect of herbal medicines on obesity: Herbal pancreatic lipase inhibitors. Wudpecker J. Med. Plants 2, 53–65 (2013).
Heo, B. G. et al. Anticancer and antioxidant effects of extracts from different parts of indigo plant. Ind. Crops Prod. 56, 9–16. https://doi.org/10.1016/j.indcrop.2014.02.023 (2014).
Aggarwal, B. B. & Harikumar, K. B. Potential therapeutic effects of curcumin: The anti-inflammatory agent against neurodegenerative cardiovascular, pulmonary, metabolic, autoimmune, and neoplastic diseases. Int. J. Biochem. Cell Biol. 41, 40–59 (2009).
Chainani-Wu, N. Safety and anti-inflammatory activity of curcumin: A component of tumeric (Curcuma longa). J. Altern. Complement Med. 9(1), 161–168. https://doi.org/10.1089/107555303321223035 (2003).
De, R. et al. Antimicrobial activity of curcumin against Helicobacter pylori isolates from India and during infections in mice. Antimicrob. Agents Chemother. 53, 1592–1597 (2009).
Wang, Y., Lu, Z., Wu, H. & Lv, F. Study on the antibiotic activity of microcapsule curcumin against foodborne pathogens. Int. J. Food Microbiol. 136, 71–74 (2009).
Ramesh, G., Kaviyil, J. E., Paul, W., Sasi, R., Joseph, R., (2022). Gallium–curcumin nanoparticle conjugates as an antibacterial agent against Pseudomonas aeruginosa: Synthesis and characterization ACS Omega, 7, 6795–6809
Mosieniak, G. et al. Curcumin induces permanent growth arrest of human colon cancer cells: Link between senescence and autophagy. Mech. Ageing Dev. 133, 444–455. https://doi.org/10.1016/j.mad.2012.05.004 (2012).
Kim, K. C. & Lee, C. H. Curcumin induces downregulation of E2F4 expression and apoptotic cell death in HCT116 human colon cancer cells; involvement of reactive oxygen species. Korean J. Physiol. Pharmacol. 14, 391–397. https://doi.org/10.4196/kjpp.2010.14.6.391 (2010).
Ismail, N. I., Othman, I., Abas, F., Lajis, N. & Naidu, R. Mechanism of apoptosis induced by curcumin in colorectal cancer. Int. J. Mol. Sci. 20, 2454. https://doi.org/10.3390/ijms20102454 (2019).
Anand, P., Kunnumakkara, A. B., Newman, R. A. & Aggarwal, B. B. Bioavailability of curcumin: Problems and promises. Mol. Pharm. 4, 807–818. https://doi.org/10.1021/mp700113r (2007).
Wang, H. et al. Characterization, release, and antioxidant activity of curcumin-loaded sodium alginate/ZnO hydrogel beads. Int. J. Biol. Macromol. 121, 1118–1125 (2019).
Suryani, M. R. & Ismail, H. Preparation of curcumin nanoparticles and cellular uptake study on HeLa cells. In International Conference on Latest Trends in Food, Biological & Ecological Sciences (ICLTFBE'15) Oct. 11–12, Dubai (UAE) (2015).
Elbialy, N. S., Aboushoushah, S. F. & Alshammari, W. W. Long-term biodistribution and toxicity of curcumin capped iron oxide nanoparticles after single-dose administration in mice. Life Sci. 230, 76–83 (2019).
Elbialy, N. S., Aboushoushah, S. F., Sofi, B. F. & Noorwali, A. Multifunctional curcumin-loaded mesoporous silica nanoparticles for cancer chemoprevention and therapy. Microporous Mesoporous Mater. 291, 109540 (2020).
Ben, Y. G. M. et al. Curcumin protects skin against UVB-induced cytotoxicity via the Keap1-Nrf2 pathway: The use of a microemulsion delivery system. Oxid. Med. Cell. Longev. 17, 5205471 (2017).
Ben, Y. G. M., Frusic-Zlotkin, M., Soroka, Y. & Bitton, R. Nitroxide delivery system for Nrf2 activation and skin protection. Eur. J. Pharm. Biopharm. 94, 123–134 (2015).
Kesisoglou, F. & Panmai, S. Application of nanoparticles in oral delivery of immediate release formulations. Curr. Nanosci. 3, 183–190 (2007).
Avgoustakis, K. et al. PLGA-mPEG nanoparticles of cisplatin: In vitro nanoparticle degradation, in vitro drug release and in vivo drug residence in blood properties. J. Control Release 79(1–3), 123–135 (2002).
Mutar, T. F., Tousson, E., Hafez, E., Gazia, M. A. & Salem, S. B. Ameliorative effects of vitamin B17 on the kidney against Ehrlich ascites carcinoma induced renal toxicity in mice. Environ. Toxicol. 35(4), 528–537 (2020).
Abdelrahman, I. Y., El-Kashef, H. & Hassan, N. H. Anti-tumor efect of green tea extract, simvastatin, and gamma radiation on solid tumor in mice. Arab. J. Nucl. Sci. Appl. 53(4), 39–52 (2020).
Ghous, Z., Akhter, J., Pourgholami, M. H. & Morris, D. L. Inhibition of hepatocellular cancer by EB1089: In vitro and in vivo study. Anticancer Res. 28, 3757–3762 (2008).
Moller, P., Knudsen, L. E., Loft, S. & Wallin, H. The comet assay as a rapid test in biomonitoring occupational exposure to DNA damaging agents and effect of confounding factors. Cancer Epidemiol. Biomark. Prev. 9(10), 1005–1015 (2000).
Rageh, M. M. & El-Gebaly, R. H. Melanin nanoparticles: Antioxidant activities and effects on γ-ray-induced DNA damage in the mouse. Mutat. Res. Gen. Toxicol. Environ. 828, 15–22 (2018).
Moller, P. The alkaline comet assay: Towards validation in biomonitoring of DNA damaging exposures. Basic Clin. Pharmacol. Toxicol. 98, 336–345 (2006).
Lihua, W. et al. Curcumin derivative WZ35 inhibits tumor cell growth via ROS-YAP-JNK signaling pathway in breast cancer. J. Exp. Clin. Cancer Res. 38, 460 (2019).
Denning, M. F., Wang, Y., Nickoloff, B. J. & Wrone-Smith, T. Protein kinase Cdelta is activated by caspase-3 dependent proteolysis during ultraviolet radiation-induced apoptosis of human keratinocytes. J. Biol. Chem. 273, 29995–30002 (1998).
Kuo, Y. C. & Liang, C. T. Inhibition of human brain malignant glioblastoma cells using carmustine-loaded catanionic solid lipid nanoparticles with surface anti-epithelial growth factor receptor. Biomaterials 32(12), 3340–3350 (2011).
Catania, A., Barrajon-Catalan, E., Nicolosi, S., Cicirata, F. & Micol, V. Immunoliposome encapsulation increases cytotoxic activity and selectivity of curcumin and resveratrol against HER2 overexpressing human breast cancer cells. Breast Cancer Res. Treat. 141, 55–65 (2013).
Sun, M. et al. Advances in nanotechnology-based delivery systems for curcumin. Nanomedicine 7, 1085–1100 (2012).
Mohanty, C., Acharya, S., Mohanty, A. K., Dilnawaz, F. & Sahoo, S. K. Curcumin-encapsulated MePEG/PCL diblock copolymeric micelles: A novel controlled delivery vehicle for cancer therapy. Nanomedicine 5, 433–449 (2010).
Lee, M. K., Lim, S. J. & Kim, C. K. Preparation, characterization and in vitro cytotoxicity of paclitaxel-loaded sterically stabilized solid lipid nanoparticles. Biomaterials 28(12), 2137–2146 (2007).
Paolino, D., Fresta, M., Sinha, P. & Ferrari, M. Drug delivery systems. In Encyclopedia of Medical Devices and Instrumentation 2nd edn (ed. Webster, J. G.) 437–495 (Wiley, 2006).
Pandit, R. S., Gaikwad, S. C., Agarkar, G. A., Gade, A. K. & Rai, M. Curcumin nanoparticles: Physicochemical fabrication and it’s in vitro efficacy against human pathogens. 3 Biotech 5, 991–997 (2015).
Kumar, V. et al. Preparation and characterization of nanocurcumin based hybrid virosomes as a drug delivery vehicle with enhanced anticancerous activity and reduced toxicity. Sci. Rep. 11, 368. https://doi.org/10.1038/s41598-020-79631-1 (2021).
Yallapu, M. M., Jaggi, M. & Chauhan, S. C. β-Cyclodextrin-curcumin self-assembly enhances curcumin delivery in prostate cancer cells. Colloids Surf. B 79, 113–125 (2010).
Mohamad, E. A. & Fahmy, H. M. Niosomes and liposomes as promising carriers for dermal delivery of Annona squamosa extract. Braz. J. Pharm. Sci. 56, e18096 (2020).
Zhao, Z. et al. Formation of curcumin nanoparticles via solution enhanced dispersion by supercritical CO2. Int. J. Nanomed. 10, 3171–3181 (2015).
Gustavo, V. et al. Curcumin and quercetin loaded nanoemulsion: Physicochemical compatibility study and validation of a simultaneous quantification method. Nanomaterials 10, 1650. https://doi.org/10.3390/nano10091650 (2010).
Marcela, S. V. et al. Characterization of curcumin-loaded lecithin-chitosan bioactive nanoparticles. Carbohyd. Polym. Technol. Appl. 2, 100119. https://doi.org/10.1016/j.carpta.2021.100119 (2021).
Lin, S. & Kao, Y. Solid particulates of drug β-cyclodextrin inclusion complexes directly prepared by spray drying technique. Int. J. Pharm. 56, 249–259 (1989).
Mohamad, E. A., Rageh, M. M. & Darwish, M. M. A sunscreen nanoparticles polymer based on prolonged period of protection. J. Bioact. Compat. Polym. 37(1), 17–27 (2022).
Hossann, M. et al. Proteins and cholesterol lipid vesicles are mediators of drug release from thermosensitive liposomes. J. Control Release 162, 400–406 (2012).
Wenrui, W. et al. Enhanced bioavailability and efficiency of curcumin for the treatment of asthma by its formulation in solid lipid nanoparticles. Int. J. Nanomed. 7, 3667–3677 (2012).
Kudryavtseva, A. V. et al. Mitochondrial dysfunction and oxidative stress in aging and cancer. Oncotarget 7, 44879 (2016).
Gupta, A., Bhatt, M. L. B. & Misra, M. K. Lipid peroxidation and antioxidant status in head and neck squamous cell carcinoma patients. Oxid. Med. Cell Longev. 2(2), 68–72 (2009).
Rageh, M. M., El-Garhy, M. R. & Mohamad, E. A. Magnetic fields enhance the anti-tumor efficacy of low dose cisplatin and reduce the nephrotoxicity. Naunyn-Schmiedeberg’s Arch. Pharmacol. 393(8), 1475–1485 (2020).
Urruticoechea, A. et al. Recent advances in cancer therapy: An overview. Curr. Pharm. Des. 16(1), 3–10 (2010).
Kyung, K. J. et al. Inhibitory effect of curcumin on nitric oxide production from lipopolysaccharide-activated primary microglia. Life Sci. 79, 2022–2031 (2006).
John, T. P. et al. Mechanisms of anticarcinogenic properties of curcumin: The effect of curcumin on glutathione linked detoxification enzymes in rat liver. Int. J. Biochem. Cell Biol. 30, 445–456 (1998).
Kandemir, F. M., Benzer, F., Yildirim, N. C. & Ozdemir, N. Compensatory effects of curcumin on cisplatin-induced toxicity in rabbit testis. J. Med. Plants Res. 5(3), 456–461 (2010).
Tao, G., Cunjun, H., Yunjian, H., Yi, L. & Yun, L. Effects of curcumin pretreatment on cell proliferation, oxidative stress, and Nrf2 pathways in HK-2 cells cultured in high glucose medium. Int. J. Clin. Exp. Med. 11(12), 13422–13428 (2018).
Collins, A. R. et al. The comet assay: Topical issues. Mutagenesis 23, 143–151 (2008).
Stephens, N. P. & Singh, R. E. X-ray-induced double-strand breaks in human sperm. Mutagenesis 13, 75–79 (1998).
Gupta, N. et al. Free radicals as a double-edged sword: The cancer preventive and therapeutic roles of curcumin. Molecules 25(22), 5390 (2020).
Morin, D., Barthélémy, S., Zini, R., Labidalle, S. & Tillement, J.-P. Curcumin induces the mitochondrial permeability transition pore mediated by membrane protein thiol oxidation. FEBS Lett. 495, 131–136 (2001).
Wang, X. The expanding role of mitochondria in apoptosis. Genes Dev. 15(22), 2922–2933 (2001).
Wang, J., Li-li, Q., Zheng, S. & Tian-xing, W. Curcumin induces apoptosis through the mitochondria-mediated apoptotic pathway in HT-29 cells. J. Zhejiang Univ. Sci. B 10(2), 93–102 (2009).
Monem, A. S., Sayed, F., Rageh, M. M. & Mohamed, N. Cytotoxicity and genotoxicity of gold nanorods assisted photothermal therapy against Ehrlich carcinoma in-vivo. Life Sci. 257, 118108 (2020).
Funding
Open access funding provided by The Science, Technology & Innovation Funding Authority (STDF) in cooperation with The Egyptian Knowledge Bank (EKB).
Author information
Authors and Affiliations
Contributions
M.R. and E.M. created and designed research and analyzed data. E.A. and M.S. performed experiments and contributed new reagents or analytical tools. M.R. wrote the manuscript. All authors read and approved the manuscript.
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing interests.
Additional information
Publisher's note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary Information
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Rageh, M.M., Abdelmoneam, E.A., Sharaky, M. et al. Physico-chemical properties of curcumin nanoparticles and its efficacy against Ehrlich ascites carcinoma. Sci Rep 13, 20637 (2023). https://doi.org/10.1038/s41598-023-47255-w
Received:
Accepted:
Published:
DOI: https://doi.org/10.1038/s41598-023-47255-w
This article is cited by
-
Niosomes loading N-acetyl-L-cysteine for cancer treatment in vivo study
Naunyn-Schmiedeberg's Archives of Pharmacology (2023)
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.